Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
RedHill Biopharma secures $4 million strategic investment from Cumberland Pharmaceuticals for Talicia co-commercialization, enhancing sales growth.
Amount Raised
$4 Million
Round Type
Corporate Round
Investors
Description
RedHill Biopharma announced a strategic partnership with Cumberland Pharmaceuticals, where Cumberland will invest $4 million for a 30% stake in RedHill's Talicia business. This partnership aims to accelerate Talicia's sales growth through joint marketing efforts. With shared operational responsibilities, RedHill retains 70% ownership. The deal reinforces RedHill's financial position for future strategic objectives.
Fundz sees it the moment RedHill Biopharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
RedHill Biopharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.